[Social media-Chances and risks for rheumatology].

I Haase, J Mucke, D Vossen, J Knitza, N Ruffer, M Zeeck, M Krusche

Abstract readReview

In one paragraph

Review in Zeitschrift fur Rheumatologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

[Autoinflammatory syndromes].Zeitschrift fur Rheumatologie · 2023
Review
[Autoinflammatory syndromes].Innere Medizin (Heidelberg, Germany) · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

I HaaseArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

J MuckeArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

D VossenArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

J KnitzaArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

N RufferArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

M ZeeckArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland.

M KruscheArbeitsgemeinschaft Junge Rheumatologie, Deutsche Gesellschaft für Rheumatologie e. V., Berlin, Deutschland. m.krusche@uke.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of social media and social networks has increased significantly in recent years. They are becoming progressively more important as information channels in private and professional contexts. Also, in medicine, social media are already being used in a variety of ways. For example, professional societies and patient interest groups are being increasingly represented in social networks. The broad use and wide audience of these networks offer new opportunities for the field of rheumatology. This review article provides an overview of the characteristics of some major social media platforms and systematically analyses the existing publications in the context of rheumatology. Furthermore, advantages, but also potential risks that may arise due to social media use are being addressed.

Indexed as

RheumatologySocial MediaHumansAwarenessCrowd sourcingData protectionEducationInfluencerLinkPersonal rightsPlatformSocial networks

Identifiers

PMID35394194

DOI10.1016/j.psc.2019.05.004

PMCPMC8990654

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.